Skip to main navigation Skip to search Skip to main content

Betulinic Acid and its Derivatives as Potential Antitumor Agents

  • Dong Mei Zhang
  • , Hong Gui Xu
  • , Lei Wang
  • , Ying Jie Li
  • , Ping Hua Sun
  • , Xiao Ming Wu
  • , Guang Ji Wang
  • , Wei Min Chen
  • , Wen Cai Ye

Research output: Contribution to journalArticlepeer-review

187 Scopus citations

Abstract

Betulinic acid (BA) is a lupane-type pentacyclic triterpene, distributed ubiquitously throughout the plant kingdom. BA and its derivatives demonstrate multiple bioactivities, particularly an antitumor effect. This review critically describes the recent research on isolation, synthesis, and derivatization of BA and its natural analogs betulin and 23-hydroxybetulinic acid. The subsequent part of the review focuses on the current knowledge of antitumor properties, combination treatments, and pharmacological mechanisms of these compounds. A 3D-QSAR analysis of 62 BA derivatives against human ovarian cancer A2780 is also included to provide information concerning the structure-cytotoxicity relationships of these compounds.

Original languageEnglish
Pages (from-to)1127-1155
Number of pages29
JournalMedicinal Research Reviews
Volume35
Issue number6
DOIs
StatePublished - Nov 2015
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Antitumor effect
  • Betulinic acid
  • Derivatives
  • Structure-cytotoxicity relationship

Fingerprint

Dive into the research topics of 'Betulinic Acid and its Derivatives as Potential Antitumor Agents'. Together they form a unique fingerprint.

Cite this